HIT — Stock Film
STOCK FILMSCENE 1/11HIT · $1.03
Stock Expert AI presents
HIT
Health In Tech, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Health In Tech, Inc. A quick introduction.

On the stock market since 2024, it operates in the world of technology. It has 91 employees. Now — the numbers.

on the stock market since 2024
91 employees
$57.1M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $4 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 4%

This is an established company with proven profits.

THE SALES TREND
Sales are growing, year after year.

Average growth of 79% a year over the last 3 years. Every year shown ended in profit.

$5.8M
2022
$19.2M
2023
$19.5M
2024
$33.3M
2025
Cash on hand:
$0
Total debt:
$0
The cash outweighs the debt.

If every debt were paid off today, $7.5M would still be left in the vault — a solid cushion for hard times.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
30
very weak

Clearly below the class average.

FINANCIAL STRENGTH
30
very weak

Clearly below the class average.

VALUATION
24
very weak

Clearly below the class average.

GROWTH
81
very strong

Sales are growing strongly for its sector.

PRICE MOMENTUM
21
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 86% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 79% a year on average.

2
THE BRIGHT SIDE · 2/3
Strong cash, light debt

There is $7.7M in the vault; even if every debt were paid off, $7.5M would remain.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $3.50241% above today’s price.

1
THE RISKS · 1/2
A wildly swinging price

This stock swings about 2.9 times as much as the market average. Big rallies — and big drops — can both happen fast.

2
THE RISKS · 2/2
A rich price tag

The company’s market value is 45 times its annual profit. Even a small disappointment could hit the price hard.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, HIT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: HIT is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.

Analysts’ average target sits above today’s price, yet the valuation grade (24/100) says the stock isn’t cheap.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film